Drug Shortage Report for TOMUDEX
Report ID | 222272 |
Drug Identification Number | 02229566 |
Brand name | TOMUDEX |
Common or Proper name | TOMUDEX |
Company Name | PFIZER CANADA ULC |
Market Status | MARKETED |
Active Ingredient(s) | RALTITREXED |
Strength(s) | 2MG |
Dosage form(s) | POWDER FOR SOLUTION |
Route of administration | INTRAVENOUS INTRAVENOUS |
Packaging size | 1 x 2mg |
ATC code | L01BA |
ATC description | ANTIMETABOLITES |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2024-03-14 |
Estimated end date | 2024-06-30 |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2024-04-24 |
Company comments | Ordering restrictions will apply. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 17300 TRANS-CANADA HIGHWAY KIRKLAND, QUEBEC CANADA H9J 2M5 |
Company contact information | Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v5 | 2024-04-24 | French | Compare |
v4 | 2024-04-24 | English | Compare |
v3 | 2024-03-15 | English | Compare |
v2 | 2024-03-14 | French | Compare |
v1 | 2024-03-14 | English | Compare |
Showing 1 to 5 of 5